Search and analyze individual stocks with comprehensive metrics
Amwill Health Care Ltd
Fundamental Score
Amwill Health Care Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AMWILL across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (24.85%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (27.56%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (23.43%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 10.64 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (70.65%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Profit Decline Concern (-40.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-8.42%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Institutional Interest (FII+DII: 1.16%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Amwill Health Care Ltd
About AMWILL
Business Overview
Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, miscellaneous, peri-orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, and anti-scabies, as well as cosmeceutical and aesthetic categories. The company was founded in 2009 and is headquartered in Bengaluru, India.
Company Details
Key Leadership
Latest News
AMWILL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Amwill Health Care Ltd (AMWILL)?
As of 16 Jan 2026, 10:14 am IST, Amwill Health Care Ltd (AMWILL) is currently trading at ₹41.79. The stock has a market capitalization of ₹85.98 (Cr).
Is AMWILL share price Overvalued or Undervalued?
AMWILL is currently trading at a P/E ratio of 10.64x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Amwill Health Care Ltd share price?
Key factors influencing AMWILL's price include its quarterly earnings growth (Sales Growth: -8.42%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Amwill Health Care Ltd a good stock for long-term investment?
Amwill Health Care Ltd shows a 5-year Profit Growth of N/A% and an ROE of 24.85%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Amwill Health Care Ltd compare with its industry peers?
Amwill Health Care Ltd competes with major peers in the Pharmaceuticals. Investors should compare AMWILL's P/E of 10.64x and ROE of 24.85% against the industry averages to determine its competitive standing.
What is the P/E ratio of AMWILL and what does it mean?
AMWILL has a P/E ratio of 10.64x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹11 for every ₹1 of annual earnings.
How is AMWILL performing according to Bull Run's analysis?
AMWILL has a Bull Run fundamental score of 36.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does AMWILL belong to?
AMWILL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amwill Health Care Ltd.
What is Return on Equity (ROE) and why is it important for AMWILL?
AMWILL has an ROE of 24.85%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Amwill Health Care Ltd generates profits from shareholders' equity.
How is AMWILL's debt-to-equity ratio and what does it indicate?
AMWILL has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is AMWILL's dividend yield and is it a good dividend stock?
AMWILL offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has AMWILL grown over the past 5 years?
AMWILL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in AMWILL and why does it matter?
Promoters hold 70.65% of AMWILL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is AMWILL's market capitalization category?
AMWILL has a market capitalization of ₹86 crores, placing it in the Small-cap category.
How volatile is AMWILL stock?
AMWILL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for AMWILL?
AMWILL has a 52-week high of ₹N/A and low of ₹N/A.
What is AMWILL's operating profit margin trend?
AMWILL has a 5-year average Operating Profit Margin (OPM) of 23.43%, indicating the company's operational efficiency.
How is AMWILL's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -8.42% and YoY Profit Growth of -40.64%.
What is the institutional holding pattern in AMWILL?
AMWILL has FII holding of 1.16% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.